The medical device maker topped second-quarter expectations but now sees full-year adjusted EPS of $3.28 to $3.32, down from a prior range of $3.34 to $3.41 ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-07-29 06:02:00
















